Assertio Therapeutics Inc (ASRT) — Net Asset Quality Index
Assertio Therapeutics Inc (ASRT) has a Net Asset Quality Index of 35.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $211.30 Million minus total liabilities of $135.67 Million yields net assets of $75.63 Million. A higher index indicates a stronger, lower-leverage balance sheet. See how many days can Assertio Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Assertio Therapeutics Inc Net Asset Quality Index Over Time (1996–2025)
This chart shows how Assertio Therapeutics Inc's Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2025. As of March 2026, the index stands at 35.8%, representing net assets of $75.63 Million against total assets of $211.30 Million USD. Explore how efficiently does Assertio Therapeutics Inc generate cash to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Assertio Therapeutics Inc (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Assertio Therapeutics Inc from 1996 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Assertio Therapeutics Inc (ASRT) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.2% | $93.95 Million | $266.97 Million | $173.02 Million | ▼ -7.3 pp |
| 2024 | 42.5% | $121.08 Million | $284.73 Million | $163.65 Million | ▼ -5.7 pp |
| 2023 | 48.2% | $138.00 Million | $286.42 Million | $148.42 Million | ▼ -6.4 pp |
| 2022 | 54.5% | $225.72 Million | $413.91 Million | $188.19 Million | ▲ +23.2 pp |
| 2021 | 31.4% | $102.41 Million | $326.55 Million | $224.13 Million | ▲ +13.1 pp |
| 2020 | 18.3% | $55.51 Million | $303.27 Million | $247.76 Million | ▲ +7.3 pp |
| 2019 | 11.0% | $57.96 Million | $527.17 Million | $469.21 Million | ▼ -12.6 pp |
| 2018 | 23.6% | $220.34 Million | $932.87 Million | $712.53 Million | ▲ +7.3 pp |
| 2017 | 16.3% | $169.51 Million | $1.04 Billion | $869.11 Million | ▼ -4.1 pp |
| 2016 | 20.5% | $250.79 Million | $1.23 Billion | $974.55 Million | ▼ -2.6 pp |
| 2015 | 23.1% | $315.06 Million | $1.36 Billion | $1.05 Billion | ▼ -28.1 pp |
| 2014 | 51.3% | $364.45 Million | $711.07 Million | $346.62 Million | ▲ +24.2 pp |
| 2013 | 27.0% | $137.42 Million | $508.65 Million | $371.24 Million | ▼ -32.2 pp |
| 2012 | 59.3% | $83.94 Million | $141.65 Million | $57.72 Million | ▼ -5.2 pp |
| 2011 | 64.4% | $105.92 Million | $164.37 Million | $58.45 Million | ▲ +37.9 pp |
| 2010 | 26.5% | $23.11 Million | $87.03 Million | $63.92 Million | ▲ +9.4 pp |
| 2009 | 17.2% | $15.73 Million | $91.58 Million | $75.86 Million | ▼ -17.7 pp |
| 2008 | 34.9% | $33.15 Million | $95.08 Million | $61.93 Million | ▼ -21.6 pp |
| 2007 | 56.4% | $45.52 Million | $80.64 Million | $35.12 Million | ▲ +108.3 pp |
| 2006 | -51.9% | $-27.29 Million | $52.62 Million | $79.91 Million | ▼ -62.0 pp |
| 2005 | 10.2% | $6.76 Million | $66.38 Million | $59.62 Million | ▼ -26.6 pp |
| 2004 | 36.7% | $8.40 Million | $22.87 Million | $14.47 Million | ▼ -35.8 pp |
| 2003 | 72.5% | $34.58 Million | $47.69 Million | $13.12 Million | ▲ +100.2 pp |
| 2002 | -27.7% | $-6.41 Million | $23.18 Million | $29.59 Million | ▼ -10.8 pp |
| 2001 | -16.9% | $-1.48 Million | $8.75 Million | $10.22 Million | ▼ -69.4 pp |
| 2000 | 52.5% | $4.59 Million | $8.73 Million | $4.15 Million | ▲ +11.4 pp |
| 1999 | 41.1% | $9.22 Million | $22.43 Million | $13.22 Million | ▼ -48.2 pp |
| 1998 | 89.3% | $9.20 Million | $10.30 Million | $1.10 Million | ▲ +0.2 pp |
| 1997 | 89.1% | $4.10 Million | $4.60 Million | $500.00K | ▲ +222.5 pp |
| 1996 | -133.3% | $-400.00K | $300.00K | $700.00K | — |